$CRTO
Criteo S.A. Stock $crto

$crto Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000157642721000056 Filed on August 04, 2021

Income Statement

Concept	2021 Q2	2020 Q2
Revenue	$551.3M	$437.6M
YoY Change	25.98%	-17.14%
Cost Of Revenue	$331.1M	$257.7M
YoY Change	28.48%	-15.29%
Gross Profit	$182.9M	$146.0M
YoY Change	25.25%	-25.07%
Gross Profit Margin	33.17%	33.36%
Selling, General & Admin	$121.2M	$105.0M
YoY Change	15.49%	-20.04%
% of Gross Profit	66.29%	71.89%
Research & Development	$41.92M	$31.25M
YoY Change	34.14%	-29.01%
% of Gross Profit	22.92%	21.4%
Depreciation & Amortization	$25.16M	$27.91M
YoY Change	-9.84%	52.65%
% of Gross Profit	13.76%	19.11%
Operating Expenses	$163.1M	$136.2M
YoY Change	19.77%	-22.29%
Operating Profit	$19.73M	$9.789M
YoY Change	101.54%	-49.99%
Interest Expense	$506.0K	$811.0K
YoY Change	-37.61%	68.61%
% of Operating Profit	2.56%	8.28%
Other Income/Expense, Net	-$519.0K	-$1.003M
YoY Change	-48.26%	-25.92%
Pretax Income	$19.21M	$8.786M
YoY Change	118.64%	-51.78%
Income Tax	$4.181M	$2.636M
% Of Pretax Income	21.76%	30.0%
Net Earnings	$14.80M	$5.716M
YoY Change	158.99%	-47.19%
Net Earnings / Revenue	2.69%	1.31%
Basic Earnings Per Share	$0.24	$0.09
Diluted Earnings Per Share	$0.23	$0.09
COMMON SHARES
Basic Shares Outstanding	60.66M shares	61.42M shares
Diluted Shares Outstanding	64.67M shares	61.79M shares

Balance Sheet

Concept	2021 Q2	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$543.0M	$578.2M
YoY Change	-6.09%	36.99%
Cash & Equivalents	$489.5M	$578.2M
Short-Term Investments	$53.47M
Other Short-Term Assets	$21.84M	$17.31M
YoY Change	26.2%	-7.71%
Inventory
Prepaid Expenses	$11.06M	$8.437M
Receivables	$438.7M	$330.0M
Other Receivables	$89.67M	$76.75M
Total Short-Term Assets	$1.088B	$999.4M
YoY Change	8.91%	12.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$162.0M	$195.7M
YoY Change	-17.25%	1.6%
Goodwill	$332.3M	$316.6M
YoY Change	4.97%	-0.16%
Intangibles	$88.56M	$78.19M
YoY Change	13.27%	-24.18%
Long-Term Investments	$24.77M	$42.21M
YoY Change	-41.32%	95.28%
Other Assets	$16.29M	$34.49M
YoY Change	-52.76%	-16.59%
Total Long-Term Assets	$754.0M	$805.0M
YoY Change	-6.34%	-6.35%
TOTAL ASSETS
Total Short-Term Assets	$1.088B	$999.4M
Total Long-Term Assets	$754.0M	$805.0M
Total Assets	$1.842B	$1.804B
YoY Change	2.11%	3.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$346.0M	$295.2M
YoY Change	17.2%	-12.92%
Accrued Expenses	$111.7M	$113.4M
YoY Change	-1.45%	-2.82%
Deferred Revenue	$798.0K	$75.00K
YoY Change	964.0%	-79.17%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.219M	$159.4M
YoY Change	-97.98%	7751.28%
Total Short-Term Liabilities	$556.7M	$643.0M
YoY Change	-13.42%	16.16%
LONG-TERM LIABILITIES
Long-Term Debt	$375.0K	$44.00K
YoY Change	752.27%	-97.85%
Other Long-Term Liabilities	$13.19M	$3.256M
YoY Change	304.94%	-24.75%
Total Long-Term Liabilities	$127.6M	$126.4M
YoY Change	0.99%	-26.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$556.7M	$643.0M
Total Long-Term Liabilities	$127.6M	$126.4M
Total Liabilities	$684.4M	$769.4M
YoY Change	-11.05%	6.18%
SHAREHOLDERS EQUITY
Retained Earnings	$519.9M	$452.2M
YoY Change	14.96%	12.72%
Common Stock	$722.9M	$685.4M
YoY Change	5.47%	4.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$111.8M	$90.71M
YoY Change	23.27%	241.49%
Treasury Stock Shares	6.080M shares	5.589M shares
Shareholders Equity	$1.124B	$1.003B
YoY Change
Total Liabilities & Shareholders Equity	$1.842B	$1.804B
YoY Change	2.11%	3.13%

Cashflow Statement

Concept	2021 Q2	2020 Q2
OPERATING ACTIVITIES
Net Income	$14.80M	$5.716M
YoY Change	158.99%	-47.19%
Depreciation, Depletion And Amortization	$25.16M	$27.91M
YoY Change	-9.84%	52.65%
Cash From Operating Activities	$26.36M	$33.38M
YoY Change	-21.02%	-36.98%
INVESTING ACTIVITIES
Capital Expenditures	-$13.84M	-$28.99M
YoY Change	-52.28%	-11.59%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$25.95M	-$10.78M
YoY Change	140.73%	-5256.94%
Cash From Investing Activities	-$39.78M	-$39.77M
YoY Change	0.03%	19.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$14.88M
YoY Change		15083.67%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-23.96M	$138.9M
YoY Change	-117.25%	-29394.94%
NET CHANGE
Cash From Operating Activities	26.36M	$33.38M
Cash From Investing Activities	-39.78M	-$39.77M
Cash From Financing Activities	-23.96M	$138.9M
Net Change In Cash	-37.38M	$141.7M
YoY Change	-126.38%	439.06%
FREE CASH FLOW
Cash From Operating Activities	$26.36M	$33.38M
Capital Expenditures	-$13.84M	-$28.99M
Free Cash Flow	$40.20M	$62.37M
YoY Change	-35.55%	-27.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001576427
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	161971000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	189505000	USD
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Type DocumentType	10-Q
	dei	Country Region CountryRegion	33
	dei	City Area Code CityAreaCode	40
	dei	Local Phone Number LocalPhoneNumber	40 22 90
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-36153
	dei	Entity Registrant Name EntityRegistrantName	Criteo S.A.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	I0
	dei	Entity Address Address Line1 EntityAddressAddressLine1	32 Rue Blanche
	dei	Entity Address City Or Town EntityAddressCityOrTown	Paris
	dei	Entity Address Country EntityAddressCountry	FR
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75009
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	61005559	shares
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	489521000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	488011000	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	42600000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	39900000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	438703000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	474055000	USD
CY2021Q2	crto	Prepaid Income Taxes PrepaidIncomeTaxes	13055000	USD
CY2020Q4	crto	Prepaid Income Taxes PrepaidIncomeTaxes	11092000	USD
CY2021Q2	crto	Prepaid Other Taxes And Other Taxes Receivable PrepaidOtherTaxesAndOtherTaxesReceivable	71866000	USD
CY2020Q4	crto	Prepaid Other Taxes And Other Taxes Receivable PrepaidOtherTaxesAndOtherTaxesReceivable	69987000	USD
CY2021Q2	us-gaap	Other Assets Current OtherAssetsCurrent	21841000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	21405000	USD
CY2021Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	53471000	USD
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	1088457000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	1064550000	USD
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	88558000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	79744000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	332295000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	325805000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	130104000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	114012000	USD
CY2021Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	10000000	USD
CY2020Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	41809000	USD
CY2021Q2	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	14766000	USD
CY2020Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	18109000	USD
CY2021Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	16291000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	19876000	USD
CY2021Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	753985000	USD
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	788860000	USD
CY2021Q2	us-gaap	Assets Assets	1842442000	USD
CY2020Q4	us-gaap	Assets Assets	1853410000	USD
CY2021Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	341047000	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	367025000	USD
CY2021Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	1945000	USD
CY2020Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	2250000	USD
CY2021Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3105000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2626000	USD
CY2021Q2	crto	Financial Liabilities Current FinancialLiabilitiesCurrent	3219000	USD
CY2020Q4	crto	Financial Liabilities Current FinancialLiabilitiesCurrent	2889000	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37243000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	48388000	USD
CY2021Q2	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	54697000	USD
CY2020Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	58491000	USD
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	74491000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	85272000	USD
CY2021Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	40988000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	33390000	USD
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	13185000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5535000	USD
CY2021Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	127638000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	556735000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	600331000	USD
CY2021Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4176000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5297000	USD
CY2021Q2	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	6014000	USD
CY2020Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	6167000	USD
CY2021Q2	crto	Financial Liabilities Noncurrent FinancialLiabilitiesNoncurrent	375000	USD
CY2020Q4	crto	Financial Liabilities Noncurrent FinancialLiabilitiesNoncurrent	386000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	103888000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	83007000	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	100392000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	684373000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	700723000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31247000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	73612000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	68762000	USD
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	80751000	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.025
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.025
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66697360	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66697360	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	66697360	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66272106	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66272106	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	66272106	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	2173000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	2161000	USD
CY2021Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	6080008	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5632536	shares
CY2021Q2	us-gaap	Treasury Stock Value TreasuryStockValue	111823000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	9789000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	53948000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	33591000	USD
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-519000	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1003000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1237000	USD
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	75781000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	160105000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	160755000	USD
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	40474000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29185000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	73902000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	55100000	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	163140000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	136213000	USD
	us-gaap	Operating Expenses OperatingExpenses	307619000	USD
	us-gaap	Operating Expenses OperatingExpenses	284617000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	19729000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	85570000	USD
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	720762000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	693164000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7438000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	16028000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	519893000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	491359000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1123567000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1117142000	USD
CY2021Q2	us-gaap	Minority Interest MinorityInterest	34502000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	35545000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1158069000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1152687000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1842442000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1853410000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	551311000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	437614000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1092388000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	940990000	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	331078000	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	257698000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	658745000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	555062000	USD
CY2021Q2	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	37364000	USD
CY2020Q2	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	33914000	USD
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	72076000	USD
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	67720000	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	182869000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	146002000	USD
	us-gaap	Gross Profit GrossProfit	361567000	USD
	us-gaap	Gross Profit GrossProfit	318208000	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	41915000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1337000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	19210000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8786000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	52711000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	32254000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4181000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2636000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14232000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9676000	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	15029000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	6150000	USD
	us-gaap	Profit Loss ProfitLoss	38479000	USD
	us-gaap	Profit Loss ProfitLoss	22578000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	14804000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	5716000	USD
	us-gaap	Net Income Loss NetIncomeLoss	37210000	USD
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61790135	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64371603	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61958499	shares
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-103797000	USD
	us-gaap	Net Income Loss NetIncomeLoss	21175000	USD
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	225000	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	434000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1269000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1403000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60663301	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61415467	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60702780	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61553875	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64665212	shares
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4348000	USD
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2021Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-29000	USD
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2021Q2	us-gaap	Profit Loss ProfitLoss	15029000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	6150000	USD
	us-gaap	Profit Loss ProfitLoss	38479000	USD
	us-gaap	Profit Loss ProfitLoss	22578000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	10443000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	11584000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-26540000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1357000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-658000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-377000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	10472000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	10227000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-25882000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3971000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1148000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1624000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1037988000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	25501000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	16377000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	12597000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	18607000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	25191000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	15702000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13745000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	16983000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	310000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	675000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	16428000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-14198000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	39000	USD
CY2020Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	14861000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6804000	USD
CY2020Q2	us-gaap	Stockholders Equity Other StockholdersEquityOther	-56000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1034997000	USD
CY2020Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	18239000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8131000	USD
CY2020Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	3541000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1026608000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	6150000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	10227000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1152687000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	23450000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-36354000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2151000	USD
CY2021Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4930000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6760000	USD
CY2021Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	0	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1143763000	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	15029000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	10472000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7577000	USD
CY2021Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	29999000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11227000	USD
CY2021Q2	us-gaap	Stockholders Equity Other StockholdersEquityOther	0	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1158069000	USD
CY2021Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000.0	USD
CY2021Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	943492	shares
CY2021Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	37.3
CY2021Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	496020	shares
	us-gaap	Profit Loss ProfitLoss	38479000	USD
	us-gaap	Profit Loss ProfitLoss	22578000	USD
	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	65905000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-19906000	USD
	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	65911000	USD
	crto	Depreciation Depletion And Amortization And Provisions For Various DepreciationDepletionAndAmortizationAndProvisionsForVarious	42386000	USD
	crto	Depreciation Depletion And Amortization And Provisions For Various DepreciationDepletionAndAmortizationAndProvisionsForVarious	54951000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-3959000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-2143000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	18885000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	15662000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2305000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7617000	USD
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-1655000	USD
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	727000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-25000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-45000	USD
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	662000	USD
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-1631000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-26195000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-126706000	USD
	crto	Payments To Acquire Intangible Assets Property Plant And Equipment PaymentsToAcquireIntangibleAssetsPropertyPlantAndEquipment	27616000	USD
	crto	Payments To Acquire Intangible Assets Property Plant And Equipment PaymentsToAcquireIntangibleAssetsPropertyPlantAndEquipment	40729000	USD
	crto	Increase Decrease In Accounts Payable Related To Intangible Assets Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToIntangibleAssetsPropertyPlantAndEquipment	708000	USD
	crto	Increase Decrease In Accounts Payable Related To Intangible Assets Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToIntangibleAssetsPropertyPlantAndEquipment	10460000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	9598000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5187000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-5050000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1069000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-26448000	USD
	crto	Increase Decrease In Operating Lease Liabilities Assets IncreaseDecreaseInOperatingLeaseLiabilitiesAssets	-695000	USD
	crto	Increase Decrease In Operating Lease Liabilities Assets IncreaseDecreaseInOperatingLeaseLiabilitiesAssets	120000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	103722000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	90120000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	crto	Payments For Proceeds From Change In Other Financial Noncurrent Assets PaymentsForProceedsFromChangeInOtherFinancialNoncurrentAssets	20308000	USD
	crto	Payments For Proceeds From Change In Other Financial Noncurrent Assets PaymentsForProceedsFromChangeInOtherFinancialNoncurrentAssets	20349000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56814000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-50618000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	154310000	USD
	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-1272000	USD
	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-169000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9575000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	-16000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	34929000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	33101000	USD
	crto	Proceeds From Payments For Change In Other Financial Liabilities ProceedsFromPaymentsForChangeInOtherFinancialLiabilities	-748000	USD
	crto	Proceeds From Payments For Change In Other Financial Liabilities ProceedsFromPaymentsForChangeInOtherFinancialLiabilities	-927000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-27374000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	120097000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-18024000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-181000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1510000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	159418000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	488011000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	418763000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	489521000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	578181000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	13582000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	16566000	USD
	us-gaap	Interest Paid Net InterestPaidNet	736000	USD
	us-gaap	Interest Paid Net InterestPaidNet	666000	USD
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11200000	USD
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6800000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18000000.0	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14900000	USD
	us-gaap	Restructuring Charges RestructuringCharges	5000000.0	USD
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	510000	USD
	us-gaap	Restructuring Charges RestructuringCharges	4971000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	3087000	USD
CY2021Q2	us-gaap	Restructuring Reserve RestructuringReserve	2394000	USD
CY2021Q2	us-gaap	Cash Cash	323584000	USD
CY2020Q4	us-gaap	Cash Cash	325554000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	489521000	USD
	us-gaap	Concentration Risk Credit Risk Financial Instrument Maximum Exposure ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure	610647000	USD
CY2020	us-gaap	Concentration Risk Credit Risk Financial Instrument Maximum Exposure ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure	625365000	USD
CY2021Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	165937000	USD
CY2020Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	162457000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	488011000	USD
CY2021Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	481296000	USD
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	513954000	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	42593000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	39899000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	438703000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	474055000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	39899000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	16068000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6617000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	21040000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	3469000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	6974000	USD
	crto	Allowance For Doubtful Accounts Receivable Currency Translation Adjustment AllowanceForDoubtfulAccountsReceivableCurrencyTranslationAdjustment	454000	USD
	crto	Allowance For Doubtful Accounts Receivable Currency Translation Adjustment AllowanceForDoubtfulAccountsReceivableCurrencyTranslationAdjustment	323000	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	42593000	USD
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	33294000	USD
	us-gaap	Proceeds Accounts Receivable Previously Written Off Recovery ProceedsAccountsReceivablePreviouslyWrittenOffRecovery	1700000	USD
	us-gaap	Proceeds Accounts Receivable Previously Written Off Recovery ProceedsAccountsReceivablePreviouslyWrittenOffRecovery	2300000	USD
CY2021Q2	crto	Prepayments To Suppliers PrepaymentsToSuppliers	6040000	USD
CY2020Q4	crto	Prepayments To Suppliers PrepaymentsToSuppliers	5613000	USD
CY2021Q2	crto	Other Debtors OtherDebtors	4746000	USD
CY2020Q4	crto	Other Debtors OtherDebtors	5991000	USD
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11055000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9801000	USD
CY2021Q2	us-gaap	Other Assets Current OtherAssetsCurrent	21841000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	21405000	USD
CY2021Q2	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	14054000	USD
CY2020Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	12234000	USD
CY2021Q2	us-gaap	Notes Payable Current NotesPayableCurrent	18368000	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	14433000	USD
CY2021Q2	crto	Accounts Payable Capital Expenditures AccountsPayableCapitalExpenditures	4936000	USD
CY2020Q4	crto	Accounts Payable Capital Expenditures AccountsPayableCapitalExpenditures	4721000	USD
CY2021Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	2832000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	1918000	USD
CY2021Q2	us-gaap	Variable Lease Cost VariableLeaseCost	229000	USD
CY2020Q2	us-gaap	Variable Lease Cost VariableLeaseCost	-424000	USD
CY2021Q2	us-gaap	Sublease Income SubleaseIncome	288000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	798000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	84000	USD
CY2021Q2	crto	Accounts Payable Accrued Liabilities Employee Related Payables And Taxes Payable Current AccountsPayableAccruedLiabilitiesEmployeeRelatedPayablesAndTaxesPayableCurrent	40988000	USD
CY2020Q4	crto	Accounts Payable Accrued Liabilities Employee Related Payables And Taxes Payable Current AccountsPayableAccruedLiabilitiesEmployeeRelatedPayablesAndTaxesPayableCurrent	33390000	USD
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	13334000	USD
CY2020Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	14271000	USD
CY2021Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	132000	USD
CY2020Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	-125000	USD
CY2020Q2	us-gaap	Sublease Income SubleaseIncome	-26000	USD
CY2021Q2	us-gaap	Lease Cost LeaseCost	13407000	USD
CY2020Q2	us-gaap	Lease Cost LeaseCost	13748000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	26275000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	27121000	USD
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	215000	USD
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	217000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	446000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	101000	USD
	us-gaap	Sublease Income SubleaseIncome	476000	USD
	us-gaap	Sublease Income SubleaseIncome	176000	USD
	us-gaap	Lease Cost LeaseCost	26460000	USD
	us-gaap	Lease Cost LeaseCost	27263000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	8485000	USD
CY2020	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	2232000	USD
CY2020	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	95000	USD
CY2020	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	5214000	USD
CY2020	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation	-569000	USD
	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0125
CY2020	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0085
	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.05
CY2020Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	6167000	USD
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	675000	USD
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	25000	USD
	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	658000	USD
	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation	195000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	6014000	USD
CY2020	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.05
CY2021Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	3447000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	551311000	USD
CY2020Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	4442000	USD
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	9000000	USD
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	7872000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	437614000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1092388000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	940990000	USD
CY2020Q4	crto	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNumber	7400024	shares
	crto	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsGrantsInPeriod	2256559	shares
	crto	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsExercised	425254	shares
	crto	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVested	471172	shares
	crto	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsForfeitedInPeriod	321476	shares
	crto	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsExpirationsInPeriod	0	shares
CY2021Q2	crto	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNumber	8438681	shares
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11226000	USD
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6805000	USD
CY2021Q2	crto	Share Based Compensation Expense Employee And Non Employee ShareBasedCompensationExpenseEmployeeAndNonEmployee	11670000	USD
CY2020Q2	crto	Share Based Compensation Expense Employee And Non Employee ShareBasedCompensationExpenseEmployeeAndNonEmployee	7160000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17986000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14935000	USD
	crto	Share Based Compensation Expense Employee And Non Employee ShareBasedCompensationExpenseEmployeeAndNonEmployee	18885000	USD
	crto	Share Based Compensation Expense Employee And Non Employee ShareBasedCompensationExpenseEmployeeAndNonEmployee	15662000	USD
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	198000	USD
CY2020Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	61000	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	506000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	811000	USD
CY2021Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	464000	USD
CY2020Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	638000	USD
CY2021Q2	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	42000	USD
CY2020Q2	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	173000	USD
CY2021Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-521000	USD
CY2020Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-235000	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	310000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-18000	USD
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-519000	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1003000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	326000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	443000	USD
	us-gaap	Interest Expense InterestExpense	1046000	USD
	us-gaap	Interest Expense InterestExpense	1243000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	881000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	1018000	USD
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	165000	USD
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	225000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1319000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-496000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	802000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-41000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1237000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1337000	USD
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-500000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1200000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11927000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	17293000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2305000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7617000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14232000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9676000	USD
	crto	Effective Income Tax Rate Reconciliation Estimated Tax Rate Percent EffectiveIncomeTaxRateReconciliationEstimatedTaxRatePercent	0.27
	crto	Effective Income Tax Rate Reconciliation Estimated Tax Rate Percent EffectiveIncomeTaxRateReconciliationEstimatedTaxRatePercent	0.30
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.27
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.30
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	14804000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	5716000	USD
	us-gaap	Net Income Loss NetIncomeLoss	37210000	USD
	us-gaap	Net Income Loss NetIncomeLoss	21175000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60663301	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61415467	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60702780	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61553875	shares
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	14804000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	5716000	USD
	us-gaap	Net Income Loss NetIncomeLoss	37210000	USD
	us-gaap	Net Income Loss NetIncomeLoss	21175000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60663301	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61415467	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60702780	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61553875	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3384757	shares
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	247062	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3178570	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	255685	shares
CY2021Q2	crto	Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements Options And Bspce IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsOptionsAndBSPCE	495536	shares
CY2020Q2	crto	Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements Options And Bspce IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsOptionsAndBSPCE	119516	shares
	crto	Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements Options And Bspce IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsOptionsAndBSPCE	395803	shares
	crto	Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements Options And Bspce IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsOptionsAndBSPCE	136651	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	121618	shares
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	8090	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	94450	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	12288	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64665212	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61790135	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64371603	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61958499	shares
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	858511	shares
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4324027	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	595406	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3282625	shares
CY2020Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	2250000	USD
	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	417000	USD
	crto	Loss Contingency Accrual Provision Used LossContingencyAccrualProvisionUsed	247000	USD
	crto	Loss Contingency Accrual Provision Released Not Used LossContingencyAccrualProvisionReleasedNotUsed	400000	USD
	crto	Loss Contingency Accrual Foreign Currency Translation Gain Loss LossContingencyAccrualForeignCurrencyTranslationGainLoss	-75000	USD
CY2021Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	1945000	USD
CY2021Q2	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	1945000	USD
CY2021Q2	crto	Number Of Geographical Markets In Which Entity Operates NumberOfGeographicalMarketsInWhichEntityOperates	3	market
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	551311000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	437614000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1092388000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	940990000	USD
CY2021Q2	us-gaap	Noncurrent Assets NoncurrentAssets	250529000	USD
CY2020Q4	us-gaap	Noncurrent Assets NoncurrentAssets	269249000	USD

Files In Submission

Name	View Source	Status
0001576427-21-000056-index-headers.html	Edgar Link	pending
0001576427-21-000056-index.html	Edgar Link	pending
0001576427-21-000056.txt	Edgar Link	pending
0001576427-21-000056-xbrl.zip	Edgar Link	pending
crto-20210630.htm	Edgar Link	pending
crto-20210630.xsd	Edgar Link	pending
crto-20210630_cal.xml	Edgar Link	unprocessable
crto-20210630_def.xml	Edgar Link	unprocessable
crto-20210630_htm.xml	Edgar Link	completed
crto-20210630_lab.xml	Edgar Link	unprocessable
crto-20210630_pre.xml	Edgar Link	unprocessable
exhibit311ceo10qq22021.htm	Edgar Link	pending
exhibit312cfo10qq220211.htm	Edgar Link	pending
exhibit321ceocfo10qq22021.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRTO
Criteo S.A. Stock $crto

2021 Q2 Form 10-Q Financial Statement

#000157642721000056 Filed on August 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTO Criteo S.A. Stock $crto

2021 Q2 Form 10-Q Financial Statement

#000157642721000056 Filed on August 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTO
Criteo S.A. Stock $crto